Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence, risk factors and etiologies of onychomycosis in patients with psoriasis.

The Medical journal of Malaysia·2025
Same author

The current state of understanding of oncology expanded access programs in Malaysia.

The Medical journal of Malaysia·2024
Same author

Polyhydramnios associated with rare genetic syndromes: two case reports.

Journal of medical case reports·2024
Same author

The effect of medical education and counselling on treatment adherence and disease severity in patients with acne vulgaris: a non-randomised interventional study.

The Medical journal of Malaysia·2023
Same author

Reference values for six-minute walk distance and six-minute walk work in Caucasian adults.

Pulmonology·2023
Same author

Sweet's syndrome: A review from two tertiary hospitals in Malaysia.

The Medical journal of Malaysia·2022

Related Experiment Video

Updated: Jul 15, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Diffuse jejunoileitis of Crohn's disease

W C Tan1, R N Allan

  • 1Queen Elizabeth Hospital, Birmingham.

Gut
|October 1, 1993
PubMed
Summary

Diffuse jejunoileitis, a Crohn's disease manifestation, often presents with severe symptoms and requires frequent surgery. However, this study shows a good long-term prognosis, with many patients becoming symptom-free over time.

Area of Science:

  • Gastroenterology
  • Inflammatory Bowel Disease
  • Crohn's Disease

Background:

  • Diffuse jejunoileitis is an uncommon Crohn's disease manifestation with high morbidity.
  • Limited recent research exists on its prognosis and management.
  • This study addresses the knowledge gap by analyzing long-term outcomes.

Purpose of the Study:

  • To analyze the clinical features, management, and prognosis of diffuse jejunoileitis.
  • To evaluate outcomes in patients diagnosed between 1960 and 1991.
  • To provide insights into the long-term course of this condition.

Main Methods:

  • Retrospective analysis of 34 patients with diffuse jejunoileitis diagnosed between 1960 and 1991.
  • Data collection included clinical presentation, medical and surgical treatments, and follow-up status.

More Related Videos

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion
09:22

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion

Published on: July 3, 2026

Related Experiment Videos

Last Updated: Jul 15, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion
09:22

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion

Published on: July 3, 2026

  • Mean follow-up duration was 16 years.

    • Main Results:

    • Patients presented with severe symptoms like abdominal pain, weight loss, and diarrhea, often requiring long-term corticosteroid use.
    • 82% of patients underwent surgery, with a high frequency of repeat operations, particularly in younger individuals.
    • The annual operative rate decreased significantly over time, suggesting the disease may resolve spontaneously.

    Conclusions:

    • Diffuse jejunoileitis typically affects younger patients and presents with significant symptoms.
    • While surgery is common, strictureplasty minimizes short bowel syndrome risks.
    • The long-term prognosis is generally good, with most patients achieving symptom resolution and a good quality of life.